Radhika Jeweltech Limited (NSE:RADHIKAJWE)
India · Delayed Price · Currency is INR 94.81
-0.75 (-0.78%)
Aug 13, 2025, 2:30 PM IST
Blueprint Medicines Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2017 - 2021 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2017 - 2021 |
Operating Revenue | 5,932 | 5,878 | 5,441 | 3,127 | 2,328 | 1,374 | Upgrade |
Other Revenue | 1.48 | 1.48 | 2.25 | 2.15 | 2.98 | 2.34 | Upgrade |
| 5,933 | 5,879 | 5,443 | 3,129 | 2,331 | 1,377 | Upgrade | |
Revenue Growth (YoY) | 12.01% | 8.02% | 73.93% | 34.27% | 69.32% | -20.05% | Upgrade |
Cost of Revenue | 4,766 | 4,767 | 4,535 | 2,558 | 1,852 | 1,021 | Upgrade |
Gross Profit | 1,167 | 1,112 | 907.94 | 571.68 | 478.57 | 355.22 | Upgrade |
Selling, General & Admin | 79.04 | 76.19 | 65.49 | 54.9 | 46.62 | 42.87 | Upgrade |
Other Operating Expenses | 128.61 | 142.23 | 139.26 | 105.25 | 75.52 | 40.74 | Upgrade |
Operating Expenses | 226.57 | 237.73 | 227.17 | 176.89 | 124.9 | 84.74 | Upgrade |
Operating Income | 940.85 | 874.42 | 680.78 | 394.79 | 353.68 | 270.47 | Upgrade |
Interest Expense | -30.42 | -33.13 | -23.52 | -8.62 | -4.8 | -2.98 | Upgrade |
Interest & Investment Income | 0.35 | 0.35 | 13.04 | - | - | - | Upgrade |
Other Non Operating Income (Expenses) | -2.26 | -1.71 | -1.39 | -1.23 | -0.64 | -0.27 | Upgrade |
EBT Excluding Unusual Items | 908.52 | 839.93 | 668.9 | 384.95 | 348.24 | 267.23 | Upgrade |
Gain (Loss) on Sale of Investments | 3.21 | 3.21 | 0.41 | 15.73 | 14.64 | 28.38 | Upgrade |
Gain (Loss) on Sale of Assets | - | - | - | - | 0.85 | 0.41 | Upgrade |
Other Unusual Items | -0 | -0 | - | - | - | - | Upgrade |
Pretax Income | 911.73 | 843.14 | 669.31 | 400.68 | 363.74 | 296.02 | Upgrade |
Income Tax Expense | 259.41 | 241.96 | 174.04 | 103.78 | 93.13 | 69.83 | Upgrade |
Net Income | 652.32 | 601.18 | 495.27 | 296.91 | 270.6 | 226.19 | Upgrade |
Net Income to Common | 652.32 | 601.18 | 495.27 | 296.91 | 270.6 | 226.19 | Upgrade |
Net Income Growth | 33.70% | 21.38% | 66.81% | 9.72% | 19.64% | 76.63% | Upgrade |
Shares Outstanding (Basic) | 118 | 118 | 118 | 118 | 118 | 118 | Upgrade |
Shares Outstanding (Diluted) | 118 | 118 | 118 | 118 | 118 | 118 | Upgrade |
Shares Change (YoY) | 0.09% | 0.16% | -0.07% | - | -0.04% | 0.04% | Upgrade |
EPS (Basic) | 5.52 | 5.09 | 4.20 | 2.52 | 2.29 | 1.92 | Upgrade |
EPS (Diluted) | 5.52 | 5.09 | 4.20 | 2.52 | 2.29 | 1.92 | Upgrade |
EPS Growth | 33.49% | 21.19% | 66.92% | 9.72% | 19.69% | 76.55% | Upgrade |
Free Cash Flow | - | 164.38 | -260.24 | -259.27 | -57.26 | 61.39 | Upgrade |
Free Cash Flow Per Share | - | 1.39 | -2.21 | -2.20 | -0.48 | 0.52 | Upgrade |
Dividend Per Share | - | - | 0.200 | 0.200 | 0.200 | - | Upgrade |
Gross Margin | 19.68% | 18.92% | 16.68% | 18.27% | 20.53% | 25.80% | Upgrade |
Operating Margin | 15.86% | 14.87% | 12.51% | 12.62% | 15.17% | 19.65% | Upgrade |
Profit Margin | 10.99% | 10.22% | 9.10% | 9.49% | 11.61% | 16.43% | Upgrade |
Free Cash Flow Margin | - | 2.80% | -4.78% | -8.29% | -2.46% | 4.46% | Upgrade |
EBITDA | 946.15 | 880.49 | 689.95 | 403.83 | 356.41 | 271.6 | Upgrade |
EBITDA Margin | 15.95% | 14.98% | 12.68% | 12.90% | 15.29% | 19.73% | Upgrade |
D&A For EBITDA | 5.3 | 6.07 | 9.17 | 9.04 | 2.73 | 1.13 | Upgrade |
EBIT | 940.85 | 874.42 | 680.78 | 394.79 | 353.68 | 270.47 | Upgrade |
EBIT Margin | 15.86% | 14.87% | 12.51% | 12.62% | 15.17% | 19.65% | Upgrade |
Effective Tax Rate | 28.45% | 28.70% | 26.00% | 25.90% | 25.60% | 23.59% | Upgrade |
Revenue as Reported | 5,936 | 5,883 | 5,456 | 3,146 | 2,347 | 1,443 | Upgrade |
Updated Jan 16, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.